388 related articles for article (PubMed ID: 31279037)
1. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
Campoli M; Brodland DG; Zitelli J
J Am Acad Dermatol; 2014 Apr; 70(4):630-636. PubMed ID: 24433872
[TBL] [Abstract][Full Text] [Related]
5. Utility of Debulk Specimens During Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma.
McIlwee BE; Abidi NY; Ravi M; Carr DR
Dermatol Surg; 2021 May; 47(5):599-604. PubMed ID: 33587374
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
Marrazzo G; Zitelli JA; Brodland D
J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
8. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
Blechman AB; Carucci JA; Stevenson ML
Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Squamous Cell Carcinoma of the Lip Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Nadir U; Le K; Shi K; Srivastava D; Nijhawan RI
Dermatol Surg; 2023 Dec; 49(12):1108-1111. PubMed ID: 37910651
[TBL] [Abstract][Full Text] [Related]
11. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
[TBL] [Abstract][Full Text] [Related]
13. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines.
Montuno MA; Brown B; Konda S; Motaparthi K
Dermatol Surg; 2018 Aug; 44(8):1057-1064. PubMed ID: 29746431
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Adjuvant Radiotherapy Following Negative Surgical Margins for Cutaneous Squamous Cell Carcinoma.
Miller J; Chang T; Schwartz D; Peters M; Baum C
Dermatol Surg; 2019 Sep; 45(9):1111-1116. PubMed ID: 30893176
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
[TBL] [Abstract][Full Text] [Related]
17. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
18. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck.
Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR
Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431
[TBL] [Abstract][Full Text] [Related]
19. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma.
Weisberg NK; Bertagnolli MM; Becker DS
J Am Acad Dermatol; 2000 Sep; 43(3):483-8. PubMed ID: 10954660
[TBL] [Abstract][Full Text] [Related]
20. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]